by 331812pwpadmin | Dec 31, 2025 | News/Announcement, Press Release
Idaho Falls, ID – December 30th, 2025 – International Isotopes Inc. (“INIS” or the “Company”) (OTCQB:INIS)today announced that it has filed a Certificate of Amendment in the State of Texas to change our legalname to Radnostix, Inc. Effective immediately, we will...
by 331812pwpadmin | Oct 28, 2025 | Press Release
Idaho Falls, ID – October 22th, 2025 – International Isotopes Inc. (OTCQB: INIS) (“INIS” or the “Company”), a leading provider of radiopharmaceuticals, radioisotope products, and nuclear medicine solutions, has appointment of Dr. Duke W. Fu to its Board of Directors,...
by 331812pwpadmin | Oct 28, 2025 | News/Announcement, Press Release
Idaho Falls, ID – October 21st, 2025 – International Isotopes, Inc. (OTCQB: INIS) (“INIS” or the “Company”), together with American Fuel Resources LLC (“AFR”), has submitted an application to the U.S. Nuclear Regulatory Commission (NRC) requesting consent to transfer...
by Clay Adams | Aug 25, 2025 | Press Release
Sale of product for the first six months of 2025 increased 13.5% or $820,529 Net Income (Loss) the first six months of 2025 improved 29% to a loss of $273,479 Non-GAAP EBITDA(1) the first six months of 2025 improved 151% or $142,091 IDAHO FALLS, IDAHO, August 13,...
by Clay Adams | May 20, 2025 | Press Release
Sale of product for first quarter increased 12% to $3.2 million. Nuclear Medicine Standards sale of product in the first quarter increased 73% to $1.3 million. Net Income (Loss) improved 27% to a loss of $112,694, with Non-GAAP EBITDA(1)of $7,075, and Non-GAAP...
by Clay Adams | Mar 4, 2025 | Press Release
Revenues for fourth quarter increased 24% to $3.9 million. Full year revenues increased by 13% to $13.9 million, a historical high. Net Income in the fourth quarter increased 325% to $245,819 and increased 101% to $8,574 for the full year. Full year non-GAAP EBITDA(1)...
